- Home
- FL vs AKRO Comparison
FL vs AKRO Comparison
Compare FL & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FL
- AKRO
- Stock Information
- Founded
- FL 1879
- AKRO 2017
- Country
- FL United States
- AKRO United States
- Employees
- FL N/A
- AKRO N/A
- Industry
- FL Clothing/Shoe/Accessory Stores
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- FL Consumer Discretionary
- AKRO Health Care
- Exchange
- FL Nasdaq
- AKRO Nasdaq
- Market Cap
- FL 2.1B
- AKRO 2.2B
- IPO Year
- FL N/A
- AKRO 2019
- Fundamental
- Price
- FL $22.62
- AKRO $29.71
- Analyst Decision
- FL Hold
- AKRO Strong Buy
- Analyst Count
- FL 18
- AKRO 8
- Target Price
- FL $25.67
- AKRO $46.83
- AVG Volume (30 Days)
- FL 5.0M
- AKRO 535.2K
- Earning Date
- FL 12-04-2024
- AKRO 11-08-2024
- Dividend Yield
- FL N/A
- AKRO N/A
- EPS Growth
- FL N/A
- AKRO N/A
- EPS
- FL N/A
- AKRO N/A
- Revenue
- FL $8,124,000,000.00
- AKRO N/A
- Revenue This Year
- FL $2.77
- AKRO N/A
- Revenue Next Year
- FL $2.53
- AKRO N/A
- P/E Ratio
- FL N/A
- AKRO N/A
- Revenue Growth
- FL 0.04
- AKRO N/A
- 52 Week Low
- FL $19.33
- AKRO $15.32
- 52 Week High
- FL $35.60
- AKRO $37.00
- Technical
- Relative Strength Index (RSI)
- FL 44.53
- AKRO 46.87
- Support Level
- FL $21.15
- AKRO $28.45
- Resistance Level
- FL $23.44
- AKRO $31.41
- Average True Range (ATR)
- FL 1.11
- AKRO 1.29
- MACD
- FL -0.01
- AKRO -0.15
- Stochastic Oscillator
- FL 45.67
- AKRO 37.64
About FL Foot Locker Inc.
Foot Locker Inc operates thousands of retail stores throughout the United States, Canada, Europe, Asia, Australia, and New Zealand. It also has a presence in the Middle East. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands, includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.